Riskpilot← Back to searchSign inGet full accessCephalus Consulting AB
ABDissolvedOrg 5568759384General medical practice activities · NACE 8621Est. 20110 employees
Revenue 2025
SEK 144K
-45% vs 2024
EBITDA margin
46.1%
-64% vs 2024
Equity ratio
90.6%
Financial strength
Net profit 2025
SEK 57K
-64% vs 2024
| Revenue | SEK 144K | -45% |
| EBITDA | SEK 67K | -64% |
| Net profit | SEK 57K | -64% |
| Total assets | SEK 393K | -31% |
| Equity | SEK 356K | -30% |
| Employees | 0 | — |
Legal name
Cephalus Consulting AB
Org number
5568759384
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 december 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinska konsultuppdrag, kliniska läkemedelsprövningar, undervisning inom neurologisk och estetisk medicinsk verksamhet samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 425 | 181 | 166 | 265 | 144 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 364 | 103 | 88 | 187 | 67 |
| Depreciation & amort. | −0 | −8 | −8 | −8 | −8 |
| EBIT | 364 | 95 | 80 | 178 | 58 |
| Net financials | 14 | 16 | 23 | 21 | 13 |
| Profit before tax | 378 | 111 | 103 | 200 | 71 |
| Tax | −78 | −23 | −21 | −41 | −15 |
| Net profit | 300 | 88 | 82 | 159 | 57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 889 | 703 | 590 | 572 | 393 |
| Equity | 765 | 666 | 553 | 508 | 356 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 124 | 37 | 36 | 64 | 37 |
| Total debt | 124 | 37 | 36 | 64 | 37 |
EBITDA margin
46.1%
This company
15.8%
Market median
+192% vs market
20212025
Equity ratio
90.6%
This company
38.2%
Market median
+137% vs market
20212025
Return on equity
15.9%
This company
18.4%
Market median
+14% vs market
20212025
Net profit margin
39.3%
This company
8.1%
Market median
+385% vs market
20212025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cephalus Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Johan Nyberg | Board of Directors | 0 companies |
| Helena Susanna Nyberg | Deputy Board Member | 0 companies |
| Rosi Marie Katarina Nyberg | Deputy Board Member | 0 companies |